CTSO - CYTOSORBENTS ALERT: Bragar Eagel & Squire P.C. is Investigating Cytosorbents Corporation on Behalf of Cytosorbents Stockholders and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cytosorbents Corporation ("Cytosorbents" or the "Company") (NASDAQ:CTSO) on behalf of Cytosorbents stockholders. Our investigation concerns whether Cytosorbents has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On December 28, 2023, Cytosorbents issued a press release announcing that its pivotal trial investigating the ability of its device candidate, DrugSorb®-ATR, to reduce perioperative bleeding in patients on ...